β Amyloid Gene Duplication in Alzheimer's Disease and Karyotypically Normal Down Syndrome-Reference-Cited by-同舟云学术

β Amyloid Gene Duplication in Alzheimer's Disease and Karyotypically Normal Down Syndrome

Published:1987-03-13 Issue:4794 Volume:235 Page:1390-1392
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Delabar Jean-Maurice¹,Goldgaber Dmitry²,Lamour Yvon³,Nicole Annie¹,Huret Jean-Louis⁴,de Grouchy Jean¹,Brown Paul²,Gajdusek D. Carleton²,Sinet Pierre-Marie¹

Affiliation:

1. Laboratoire de Biochimie Génétique (Professor Kamoun), J. E. CNRS 34623, Hôpital Necker, 75743 Paris Cedex 15, France.

2. Laboratory of Central Nervous System Studies, National Institute of Neurological and Communicative Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892.

3. INSERM U.161, 75014 Paris, France.

4. CHRU Le Milétrie, 86021 Poitiers, France. J. de Grouchy, INSERM U.173 and U.K 119 CNRS, Hôpital Necker, 75743 Paris Cedex 15, France.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference17 articles.

1. CYTOGENET 1985 1

2. DELABAR, J.M., REARRANGEMENT OF CHROMOSOME 21 IN ALZHEIMERS-DISEASE, ANNALES DE GENETIQUE 29: 226 (1986).

3. DELABAR J.M. unpublished data.

4. Donlon, T. A., Proceedings of the National Academy of Sciences of the United States of America 83: 4408 (1986).

5. FEASTER, W.W., DOSAGE EFFECTS FOR SUPEROXIDE DISMUTASE-1 IN NUCLEATED CELLS ANEUPLOID FOR CHROMOSOME-21, AMERICAN JOURNAL OF HUMAN GENETICS 29: 563 (1977).

Cited by 188 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biology in balance: human diploid genome integrity, gene dosage, and genomic medicine;Trends in Genetics;2022-06

2. Animal models in the study of Alzheimer's disease and Parkinson's disease: A historical perspective;Animal Models and Experimental Medicine;2022-01-27

3. Clinical genomics and contextualizing genome variation in the diagnostic laboratory;Expert Review of Molecular Diagnostics;2020-10-02

4. Utility of spontaneous animal models of Alzheimer’s disease in preclinical efficacy studies;Cell and Tissue Research;2020-04-27

5. Other Conditions Affecting Dental Implant Treatment;Dental Implant Treatment in Medically Compromised Patients;2019-10-05